loadpatents
name:-1.8456690311432
name:-0.74830389022827
name:-0.082261085510254
DWOSKIN; Linda P. Patent Filings

DWOSKIN; Linda P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DWOSKIN; Linda P..The latest application filed is for "vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse".

Company Profile
3.21.26
  • DWOSKIN; Linda P. - Lexington KY
  • Dwoskin; Linda P - Lexington KY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
App 20200290948 - DWOSKIN; Linda P. ;   et al.
2020-09-17
Vesicular Monoamine Transporter-2 Ligands And Their Use In The Treatment Of Psychostimulant Abuse
App 20200237688 - DWOSKIN; Linda P. ;   et al.
2020-07-30
Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
Grant 10,668,030 - Dwoskin , et al.
2020-06-02
Method of treating neuropathic pain
Grant 10,071,982 - Holtman , et al. September 11, 2
2018-09-11
1,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine Compounds
App 20170226072 - CROOKS; Peter A. ;   et al.
2017-08-10
Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
Grant 9,550,753 - Crooks , et al. January 24, 2
2017-01-24
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
Grant 9,540,327 - Crooks , et al. January 10, 2
2017-01-10
Method Of Treating Neuropathic Pain
App 20160340335 - HOLTMAN; Joseph R. ;   et al.
2016-11-24
Bis-quaternary ammonium salts as pain modulating agents
Grant 9,499,518 - Holtman , et al. November 22, 2
2016-11-22
Bis-quaternary Ammonium Salts As Pain Modulating Agents
App 20160279119 - HOLTMAN; Joseph R. ;   et al.
2016-09-29
1,4-Disubstituted Piperidines, 1,4-Disubstituted Piperazines, 1,4-Disubstituted Diazepines, and 1,3-Disubstituted Pyrrolidine Compounds
App 20160031840 - CROOKS; Peter A. ;   et al.
2016-02-04
Use of tris-quaternary ammonium salts as pain modulating agents
Grant 9,155,733 - Holtman , et al. October 13, 2
2015-10-13
Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
App 20140371266 - CROOKS; Peter ;   et al.
2014-12-18
Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
Grant 8,846,937 - Crooks , et al. September 30, 2
2014-09-30
Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
Grant 8,703,803 - Crooks , et al. April 22, 2
2014-04-22
Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
Grant 8,653,275 - Crooks , et al. February 18, 2
2014-02-18
Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors
Grant 8,629,163 - Crooks , et al. January 14, 2
2014-01-14
Method Of Treating Neuropathic Pain
App 20140011836 - HOLTMAN; Joseph R. ;   et al.
2014-01-09
Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
Grant 8,546,415 - Crooks , et al. October 1, 2
2013-10-01
Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids
App 20130231366 - PAPKE; Roger L. ;   et al.
2013-09-05
Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
App 20130030018 - CROOKS; Peter A. ;   et al.
2013-01-31
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
Grant 8,178,678 - Crooks , et al. May 15, 2
2012-05-15
Bis-quaternary Ammonium Salts As Pain Modulating Agents
App 20110166177 - HOLTMAN; Joseph R. ;   et al.
2011-07-07
Tris-quarternary Ammonium Salts And Methods For Modulating Neuronal Nicotinic Acetylcholine Receptors
App 20110105556 - Crooks; Peter A. ;   et al.
2011-05-05
USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS
App 20100179186 - PAPKE; Roger L. ;   et al.
2010-07-15
Use Of Tetrakis-quaternary Ammonium Salts As Pain Modulating Agents
App 20100173937 - HOLTMAN; Joseph R. ;   et al.
2010-07-08
Bis-pyrindino Containing Compounds For The Use In The Treatment Of Cns Pathologies
App 20100152237 - CROOKS; Peter A. ;   et al.
2010-06-17
Use Of Tris-quaternary Ammonium Salts As Pain Modulating Agents
App 20100120857 - HOLTMAN; Joseph R. ;   et al.
2010-05-13
Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
App 20100113511 - Crooks; Peter ;   et al.
2010-05-06
Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
App 20100069432 - Crooks; Peter ;   et al.
2010-03-18
Bis-quaternary Ammonium Salts And Methods For Modulating Neuronal Nicotinic Acetylcholine Receptors
App 20090318503 - Crooks; Peter ;   et al.
2009-12-24
Tetrakis-quaternary Ammonium Salts And Methods For Modulating Neuronal Nicotinic Acteylcholine Receptors
App 20090143424 - CROOKS; PETER A. ;   et al.
2009-06-04
Use of Lobeline Epimers in the Treatment of Central Nervous System Diseases, Pathologies, and Drug Abuse
App 20090118331 - Crooks; Peter A. ;   et al.
2009-05-07
Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
App 20080287490 - Crooks; Peter A. ;   et al.
2008-11-20
Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
App 20050261334 - Crooks, Peter A. ;   et al.
2005-11-24
Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
Grant 6,943,177 - Dwoskin , et al. September 13, 2
2005-09-13
Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
App 20030100547 - Dwoskin, Linda P. ;   et al.
2003-05-29
Bridged nicotine compounds for use in the treatment of CNS pathologies
App 20020099069 - Crooks, Peter A. ;   et al.
2002-07-25
Nicotinic receptor antagonists in the treatment of neuropharmacological disorders
Grant 5,691,365 - Crooks , et al. November 25, 1
1997-11-25
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed